Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Cytochrome P-450 aromatase is responsible for catalysing the conversion of androstendione into estrone, so its expression in endometriotic tissue could contribute to the development of endometriosis. The aims of this study were, on the one hand, to determine the presence of aromatase in eutopic and ectopic endometrium, healthy peritoneum, myometrium and leiomyomas from patients with (n = 61) and without endometriosis (n = 12) and, on the other hand, to determine the effect of peritoneal fluid (PF), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNFalpha) on aromatase activity from endometriotic stromal cells and subcutaneous adipocytes. After immunohistochemical analysis, aromatase expression was detected in the endometriotic tissue of 61% of patients, whereas the rest of the tissues, as well as those from disease-free women, were negative. Cell cultures were made to determine aromatase activity in endometriotic stromal cells and adipocytes. The addition of PF, TNFalpha and especially IL-6 (P < 0.05) stimulated the basal enzymatic activity observed in both cell types. Our findings confirm the presence of aromatase in endometriosis and probably the existence of a local estrogen production that may be stimulated by some factors such as cytokines present in the PF of these patients. Therefore, the use of aromatase inhibitors combined with immunomodulator agents could be a novel approach to be investigated in future clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aromatase is expressed by endometriotic lesions and in the eutopic endometrium of women with endometriosis causing a local secretion of estrogens, which promote the growth and invasion of endometriotic lesions and favour the onset of pain and prostaglandin-mediated inflammation (Fig. 4) [275].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [275]
Citations
Cites
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Immunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857 · cited 1×
“Although the aetiology of the disease is not well established, several immunological and biochemical alterations are present in these patients (Bulun et al., 1999; Lebovic et al., 2001).”
BackgroundAromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 4×
“, 1997, 1999) and myometrium (Bulun et al., 1994; Noble et al., 1996) of disease-free women.”
BackgroundResultInfluentialZeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Moghrabi, N., Andersson, S., Johns, A., Meng, L., Putman, M., Carr, B., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5301 · Cited by 308 · cited 2×
“Endometriosis is also a local pelvic inflammatory process, with an altered function of peritoneal immune-related cells unable to eliminate the ectopic tissue ( Wilson et al., 1994 ).”
BackgroundKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up
Waller, K. G., & Shaw, R. W. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55791-4 · Cited by 252
[45] Assay of aromatase activity
Lephart, E. D., & Simpson, E. R. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)06116-k · Cited by 242
Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis
Halme, J., Becker, S., & Wing, R. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)80037-x · Cited by 232
Cited by
Items 101–108 of 108
THE ROLE OF PROINFLAMMATORY CYTOKINES AND SOME HORMONES IN ENDOMETRIOSIS-INDUCED OSTEOPOROSIS
Alyassin, F. F., & Taher, M. A. (2015) · Thi-Qar Medical Journal · Cited by 1
Aromatase Inhibitors Use for Endometriosis Patients
Badawy, S. Z. A. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.29.004854
“The other source of estrogen that stimulates the growth of endometriosis, is the endometriotic cells due to the presence of aromatase that converts testosterone to estradiol and androstenedione to estrone [1,2].”
BackgroundGibt es neue Hoffnungsträger abseits der chirurgischen Endometriosetherapie?
Perricos, A., & Wenzl, R. J. (2023) · Die Gynäkologie · doi:10.1007/s00129-023-05158-x
Interleukin-6: A Potential Biomarker for Dysmenorrhea and Disease Severity in AdenomyosisPreprint
Tang, Y., Tian, H.-D., Su, B., He, H., Cai, X., Hu, H., & Li, J. (2025) · Research Square · doi:10.21203/rs.3.rs-7472436/v1
NEZHAT, C. R., Nezhat, F. R., Nezhat, C., Lakhi, N. A., & Nezhat, A. A. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108561440.013
Etude phénotypique des cellules endométriosiques profondes
Leconte, M. (2012) · theses.fr (ABES) · doi:10.70675/6c60e34az6799z41eaz8bacz16682a3d37ea · Cited by 1
Physiopathologie de l’endométriose : plus de pistes que d’arrivées
Dabi, Y., Zerbib, E., Favier, A., Varinot, J., Dahan, M., Ferrier, C., Touboul, C., & Ilic, J. (2026) · EMC - Gynécologie · doi:10.1016/s0246-1064(26)48145-1
Grodkowska-Szukała, K., Gąsiorowska, V., Jachimczuk, E., Jaruga, P., Smyczyńska, N., Michalak, M., Paczyna, J., Wojtanowska, E., Kozicka, J., & Mazur, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(52).2026.6455
“Despite the significant role of steroid hormones, the exact mechanisms through which disturbances in estrogen and progesterone signaling affect the initiation and progression of endometriosis remain a subject of intense research [4, 8, 9].”
Metadata
- Authors
- Velasco, I.
- Affiliations
- Universitat de Miguel Hernández d'Elx (ES)
- Corresponding author
- Velasco, I.
- ORCID
- Velasco, I.
- Venue
- Molecular Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-26
- Volume
- 12
- Issue
- 6
- Pages
- 377-381
- ISSN
- 1360-9947 (ISSN-L)
- 1460-2407
- OpenAlex
- W2164757963
- Cited by
- 108
- References
- 33
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 4 · 2016: 8 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 6
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- aromatase, endometriosis, endometriotic stromal cells, peritoneal fluid, interleukin-6, TNF-α, adipocytes, local estrogen production, aromatase inhibitors, immunomodulators, eutopic endometrium, ectopic endometrium
- MeSH terms
- Aromatase, Ascitic Fluid, Cells, Cultured, Dexamethasone, Endometriosis, Endometrium, Female, Humans, Immunohistochemistry, Menstrual Cycle, Tumor Necrosis Factor-alpha, Interleukin-6, Stromal Cells, Adipocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.